BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31319393)

  • 21. Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely Recommendations.
    Durani U; Asante D; Heien HC; Thompson CA; Halfdanarson T; Sangaralingham L; Peethambaram P; Quevedo FJ; Villasboas JC; Go RS
    JCO Oncol Pract; 2021 Apr; 17(4):e490-e496. PubMed ID: 33095693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer.
    Accordino MK; Wright JD; Vasan S; Neugut AI; Hillyer GC; Hu JC; Hershman DL
    J Clin Oncol; 2016 Aug; 34(24):2820-6. PubMed ID: 27161970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic workup of early-stage breast cancer: can we choose more wisely?
    Aks R; Peleg Hasson S; Sivan A; Kohen T; Rivo L; Yerushalmi R; Kaufman B; Sonnenblick A; Wolf I
    Breast Cancer Res Treat; 2020 Oct; 183(3):741-748. PubMed ID: 32728861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year risk of interval-invasive second breast cancer.
    Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis.
    Bahl M; Mercaldo S; McCarthy AM; Lehman CD
    Radiology; 2021 Feb; 298(2):308-316. PubMed ID: 33350890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment.
    Henderson MC; Silver M; Tran Q; Letsios EE; Mulpuri R; Reese DE; Lourenco AP; LaBaer J; Anderson KS; Alpers J; Costantini C; Rohatgi N; Ali H; Baker K; Northfelt DW; Ghosh K; Grobmyer SR; Polen W; Wolf JK
    Clin Cancer Res; 2019 Jan; 25(1):142-149. PubMed ID: 30185421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer.
    Bychkovsky BL; Guo H; Sutton J; Spring L; Faig J; Dagogo-Jack I; Battelli C; Houlihan MJ; Yeh TC; Come SE; Lin NU
    Oncologist; 2016 Dec; 21(12):1495-1501. PubMed ID: 27551013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overuse of Chest CT in Patients With Stage I and II Breast Cancer: An Opportunity to Increase Guidelines Compliance at an NCCN Member Institution.
    Dull B; Linkugel A; Margenthaler JA; Cyr AE
    J Natl Compr Canc Netw; 2017 Jun; 15(6):783-789. PubMed ID: 28596258
    [No Abstract]   [Full Text] [Related]  

  • 30. Surveillance and beliefs about follow-up care among long-term breast cancer survivors: a comparison of primary care and oncology providers.
    Risendal BC; Sedjo RL; Giuliano AR; Vadaparampil S; Jacobsen PB; Kilbourn K; BarĂ³n A; Byers T
    J Cancer Surviv; 2016 Feb; 10(1):96-102. PubMed ID: 26070279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer.
    Di Meglio A; Lin NU; Freedman RA; Barry WT; Winer EP; Vaz-Luis I
    J Natl Compr Canc Netw; 2017 Mar; 15(3):316-324. PubMed ID: 28275032
    [No Abstract]   [Full Text] [Related]  

  • 32. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent.
    Salloum RG; Hornbrook MC; Fishman PA; Ritzwoller DP; O'Keeffe Rossetti MC; Elston Lafata J
    Cancer; 2012 Nov; 118(22):5644-51. PubMed ID: 22434568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of posttreatment imaging and biomarker testing for survivors of breast cancer.
    Barton MK
    CA Cancer J Clin; 2016 May; 66(3):175-6. PubMed ID: 26991239
    [No Abstract]   [Full Text] [Related]  

  • 34. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
    Calip GS; Elmore JG; Boudreau DM
    Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of follow-up imaging on mortality in Korean breast cancer patients: A national cohort study.
    Jung SY; Kim YA; Lee DE; Joo J; Back JH; Kong SY; Lee ES
    Cancer Med; 2021 Sep; 10(18):6480-6491. PubMed ID: 34472221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.
    Yao S; Kwan ML; Ergas IJ; Roh JM; Cheng TD; Hong CC; McCann SE; Tang L; Davis W; Liu S; Quesenberry CP; Lee MM; Ambrosone CB; Kushi LH
    JAMA Oncol; 2017 Mar; 3(3):351-357. PubMed ID: 27832250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.
    Wirtz HS; Boudreau DM; Gralow JR; Barlow WE; Gray S; Bowles EJ; Buist DS
    Breast Cancer Res Treat; 2014 Feb; 143(3):541-50. PubMed ID: 24407530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
    Corso G; Gilardi L; Girardi A; De Scalzi AM; Pagani G; Rossi EMC; Montagna G; Veronesi P; Pagan E; Bagnardi V; Grana CM
    Oncology; 2020; 98(10):714-718. PubMed ID: 32516768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
    Jung NY; Yoo IR; Kang BJ; Kim SH; Chae BJ; Seo YY
    Breast Cancer; 2016 Jan; 23(1):141-148. PubMed ID: 24872087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.